Macrophages and fibroblasts during inflammation, tissue damage and organ injury

Frontiers in Bioscience

Volumn 14, Issue 10, 2009, Pages 3988-3993

  Glaros, Trevor ^a   Larsen, Michelle ^a   Li, Liwu ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Fibroblast; Inflammation; Injury; Innate immunity; Macrophage; Review; Shock; Signaling; Tissue repair

Indexed keywords

ANIMAL; CYTOLOGY; FIBROBLAST; HUMAN; INFLAMMATION; INJURY; MACROPHAGE; PATHOLOGY; REVIEW;

ANIMALS; FIBROBLASTS; HUMANS; INFLAMMATION; MACROPHAGES; WOUNDS AND INJURIES;

EID: 63849275879     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2735/3506     Document Type: Article

References (48)

1. T. Kawai and S. Akira: TLR signaling. Semin Immunol, 19(1), 24-32(2007) (Pubitemid 46498752)
2. M. H. Shaw, T. Reimer, Y. G. Kim and G. Nunez: NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr Opin Immunol, 20(4), 377-82(2008)
3. L. Peiser, S. Mukhopadhyay and S. Gordon: Scavenger receptors in innate immunity. Curr Opin Immunol, 14(1), 123-8(2002) (Pubitemid 34085116)
4. L. Helming and S. Gordon: The molecular basis of macrophage fusion. Immunobiology, 212(9-10), 785-93(2007) (Pubitemid 350246267)
5. J. R. Nofer, M. Bot, M. Brodde, P. J. Taylor, P. Salm, V. Brinkmann, T. van Berkel, G. Assmann and E. A. Biessen: FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation, 115(4), 501-8(2007) (Pubitemid 46188244)
6. A. Kutlu, B. Bozkurt, F. Ciftci and E. Bozkanat: Th1-Th2 interaction: is more complex than a see-saw? Scand J Immunol, 65(4), 393-5(2007) (Pubitemid 46481108)
7. C. N. Lumeng, J. L. Bodzin and A. R. Saltiel: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest, 117(1), 175-84(2007) (Pubitemid 46048464)
8. J. G. Dickhout, S. Basseri and R. C. Austin: Macrophage function and its impact on atherosclerotic lesion composition, progression, and stability: the good, the bad, and the ugly. Arterioscler Thromb Vasc Biol, 28(8), 1413-5(2008)
9. E. Vinuesa, G. Hotter, M. Jung, I. Herrero-Fresneda, J. Torras and A. Sola: Macrophage involvement in the kidney repair phase after ischaemia/reperfusion injury. J Pathol, 214(1), 104-13(2008)
10. J. I. Odegaard, R. R. Ricardo-Gonzalez, M. H. Goforth, C. R. Morel, V. Subramanian, L. Mukundan, A. R. Eagle, D. Vats, F. Brombacher, A. W. Ferrante and A. Chawla: Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature, 447(7148), 1116-20(2007) (Pubitemid 47014427)
11. J. A. Watts, M. A. Gellar, M. Obraztsova, J. A. Kline and J. Zagorski: Role of inflammation in right ventricular damage and repair following experimental pulmonary embolism in rats. Int J Exp Pathol, 89(5), 389-99(2008)
12. Y. Komohara, K. Ohnishi, J. Kuratsu and M. Takeya: Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol, 216(1), 15-24(2008) doi:10.1002/path.2370
13. A. Sica, P. Larghi, A. Mancino, L. Rubino, C. Porta, M. G. Totaro, M. Rimoldi, S. K. Biswas, P. Allavena and A. Mantovani: Macrophage polarization in tumour progression. Semin Cancer Biol, 18(5), 349-55(2008)
14. F. O. Martinez, A. Sica, A. Mantovani and M. Locati: Macrophage activation and polarization. Front Biosci, 13, 453-61(2008) (Pubitemid 351599757)
15. K. Nelms, A. D. Keegan, J. Zamorano, J. J. Ryan and W. E. Paul: The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol, 17, 701-38(1999) (Pubitemid 29241138)
16. A. M. Stutz, L. A. Pickart, A. Trifilieff, T. Baumruker, E. Prieschl-Strassmayr and M. Woisetschlager: The Th2 cell cytokines IL-4 and IL-13 regulate found in inflammatory zone 1/resistin-like molecule alpha gene expression by a STAT6 and CCAAT/enhancer-binding protein-dependent mechanism. J Immunol, 170(4), 1789-96(2003) (Pubitemid 36197394)
17. J. S. Welch, L. Escoubet-Lozach, D. B. Sykes, K. Liddiard, D. R. Greaves and C. K. Glass: TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J Biol Chem, 277(45), 42821-9(2002) (Pubitemid 35285658)
18. M. J. Gray, M. Poljakovic, D. Kepka-Lenhart and S. M. Morris, Jr.: Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta. Gene, 353(1), 98-106(2005) (Pubitemid 40805364)
19. C. S. Bonder, K. V. Davies, E. K. Hosszu, J. J. Finlay-Jones and P. H. Hart: IFN-gamma downregulates interleukin-4 functional activity on monocytes by multiple mechanisms. J Interferon Cytokine Res, 22(3), 287-93(2002) (Pubitemid 34499709)
20. M. Zeyda, D. Farmer, J. Todoric, O. Aszmann, M. Speiser, G. Gyori, G. J. Zlabinger and T. M. Stulnig: Human adipose tissue macrophages are of an antiinflammatory phenotype but capable of excessive proinflammatory mediator production. Int J Obes (Lond), 31(9), 1420-8(2007) (Pubitemid 47339934)
21. H. Kanda, S. Tateya, Y. Tamori, K. Kotani, K. Hiasa, R. Kitazawa, S. Kitazawa, H. Miyachi, S. Maeda, K. Egashira and M. Kasuga: MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest, 116(6), 1494-505(2006)
22. G. H. Tesch: Role of macrophages in complications of type 2 diabetes. Clin Exp Pharmacol Physiol, 34(10), 1016-9(2007) (Pubitemid 47274561)
23. J. P. Mauldin, M. H. Nagelin, A. J. Wojcik, S. Srinivasan, M. D. Skaflen, C. R. Ayers, C. A. McNamara and C. C. Hedrick: Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus. Circulation, 117(21), 2785-92(2008) (Pubitemid 351770459)
24. V. Z. Rocha, E. J. Folco, G. Sukhova, K. Shimizu, I. Gotsman, A. H. Vernon and P. Libby: Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res, 103(5), 467-76(2008)
25. P. J. Gough, I. G. Gomez, P. T. Wille and E. W. Raines: Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest, 116(1), 59-69(2006) (Pubitemid 43121791)
26. L. L. Liu, L. K. Gong, H. Wang, Y. Xiao, X. F. Wu, Y. H. Zhang, X. Xue, X. M. Qi and J. Ren: Baicalin inhibits macrophage activation by lipopolysaccharide and protects mice from endotoxin shock. Biochem Pharmacol, 75(4), 914-22(2008)
27. L. B. Moraes, A. H. Murakami, B. Fontes, R. S. Poggetti, N. van Rooijen, R. N. Younes, A. M. Heimbecker and D. Birolini: Gut ischemia/reperfusion induced acute lung injury is an alveolar macrophage dependent event. J Trauma, 64(5), 1196-200; discussion 1200-1 (2008) (Pubitemid 351972622)
28. M. S. Delbridge, B. M. Shrestha, A. T. Raftery, A. M. El Nahas and J. Haylor: FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury. Transplant Proc, 39(10), 2992-6(2007) (Pubitemid 350251451)
29. M. S. Delbridge, B. M. Shrestha, A. T. Raftery, A. M. El Nahas and J. L. Haylor: Reduction of ischemiareperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine. Transplantation, 84(2), 187-95(2007) (Pubitemid 47205752)
30. M. Zhao, L. G. Fernandez, A. Doctor, A. K. Sharma, A. Zarbock, C. G. Tribble, I. L. Kron and V. E. Laubach: Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol, 291(5), L1018-26(2006) (Pubitemid 44772064)
31. G. J. Ko, C. S. Boo, S. K. Jo, W. Y. Cho and H. K. Kim: Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion- induced acute kidney injury. Nephrol Dial Transplant, 23(3), 842-52(2008) (Pubitemid 351767562)
32. J. P. Edwards, X. Zhang, K. A. Frauwirth and D. M. Mosser: Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol, 80(6), 1298-307(2006) (Pubitemid 44904968)
33. R. Mahanonda, N. Sa-Ard-Iam, P. Montreekachon, A. Pimkhaokham, K. Yongvanichit, M. M. Fukuda and S. Pichyangkul: IL-8 and IDO expression by human gingival fibroblasts via TLRs. J Immunol, 178(2), 1151-7(2007) (Pubitemid 46095188)
34. M. L. Cho, J. H. Ju, H. R. Kim, H. J. Oh, C. M. Kang, J. Y. Jhun, S. Y. Lee, M. K. Park, J. K. Min, S. H. Park, S. H. Lee and H. Y. Kim: Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts. Immunol Lett, 108(2), 121-8(2007)
35. T. A. Wynn: Cellular and molecular mechanisms of fibrosis. J Pathol, 214(2), 199-210(2008) (Pubitemid 351160157)
36. L. M. Luttrell, Y. Daaka and R. J. Lefkowitz: Regulation of tyrosine kinase cascades by G-proteincoupled receptors. Curr Opin Cell Biol, 11(2), 177-83(1999) (Pubitemid 29164031)
37. K. J. Gordon and G. C. Blobe: Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta, 1782(4), 197-228(2008)
38. J. J. O'Shea and P. J. Murray: Cytokine signaling modules in inflammatory responses. Immunity, 28(4), 477-87(2008) (Pubitemid 351467044)
39. L. Ulloa, J. Doody and J. Massague: Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature, 397(6721), 710-3(1999)
40. M. M. Martin, J. A. Buckenberger, J. Jiang, G. E. Malana, D. L. Knoell, D. S. Feldman and T. S. Elton: TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways. Am J Physiol Lung Cell Mol Physiol, 293(3), L790-9(2007) (Pubitemid 47358842)
41. J. Hao, B. Wang, S. C. Jones, D. S. Jassal and I. M. Dixon: Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. Am J Physiol Heart Circ Physiol, 279(6), H3020-30(2000) (Pubitemid 32005893)
42. H. Zhang, R. Pi, R. Li, P. Wang, F. Tang, S. Zhou, J. Gao, J. Jiang, S. Chen and P. Liu: PPARbeta/delta activation inhibits angiotensin II-induced collagen type I expression in rat cardiac fibroblasts. Arch Biochem Biophys, 460(1), 25-32(2007) (Pubitemid 46482426)
43. D. Stewart, M. Javadi, M. Chambers, C. Gunsolly, G. Gorski and R. C. Borghaei: Interleukin-4 inhibition of interleukin-1-induced expression of matrix metalloproteinase-3 (MMP-3) is independent of lipoxygenase and PPARgamma activation in human gingival fibroblasts. BMC Mol Biol, 8, 12(2007)
44. M. I. Roson, G. Cao, S. Della Penna, S. Gorzalczany, M. Pandolfo, J. E. Toblli and B. E. Fernandez: Angiotensin II increases intrarenal transforming growth factor-beta1 in rats submitted to sodium overload independently of blood pressure. Hypertens Res, 31(4), 707-15(2008) (Pubitemid 351772862)
45. A. K. Ghosh, J. Wei, M. Wu and J. Varga: Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-gamma. Biochem Biophys Res Commun, 374(2), 231-6(2008)
46. A. K. Ghosh, S. Bhattacharyya, G. Lakos, S. J. Chen, Y. Mori and J. Varga: Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Arthritis Rheum, 50(4), 1305-18(2004) (Pubitemid 38480842)
47. F. C. Brosius, 3rd: New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy. Rev Endocr Metab Disord (2008)
48. Y. Qian, E. Feldman, S. Pennathur, M. Kretzler and F. C. Brosius, 3rd: From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes, 57(6), 1439-45(2008)